Drug Database
Back to search

Poland· PL-100205124

Nystatyna Teva

A nystatin product containing nystatinum, registered in Poland by Teva Pharmaceuticals Polska Sp. z o.o.. The same ATC class is registered in 13 of our 19 countries.

ATC A07AA02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedNystatyna TevaATCA07AA02REGISTER NO.PL-100205124PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about nystatinumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Nystatin is registered in 13 of 19 countries.

Countries holding a registration under ATC A07AA02 (nystatin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose
Search nystatin products by name

Nystatin · ATC A07AA02

13 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Nystatinum
Manufacturer
Teva Pharmaceuticals Polska Sp. z o.o.
Country
Poland (PL)
ATC code
A07AA02
ATC class
Nystatin
Defined daily dose
1.5 MIO, E
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909990231515
  • gtin
    05909991307240

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

436 interactions on record for nystatin.

Graded by severity as the source publishes them — 436 info. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check nystatin against other medicinesHow interaction checks work

Nystatin · interactions on record

436 records

  • 436 info

Most severe, free to view

    Mechanism and what to do, in the interaction check
    Interaction register. Grades as the source publishes them.

    Same medicine, other countries

    Nystatin in 16 other countries

    What each register calls a product with the same active substance — salts and hydrates count as the same.

    All nystatin products

    Authorised across Europe · EMA

    The same active substance is authorised in 26 EEA countries. Names it is sold under:

    • Austria · Candio, Mycostatin
    • Belgium · Nilstat, Skandyra
    • Bulgaria · Нистатин Абр, Нистатин Актавис
    • Cyprus · Nystamysyn, Restatin
    • Czechia · Fungicidin Léčiva
    • Germany · Adiclair, Biofanal
    • Denmark · Nystatin Orifarm, Nystimex
    • Spain · Mycostatin
    • Finland · Nystatin Orifarm, Nystimex
    • France · Mycostatine
    • United Kingdom (Northern Ireland) · Nystan, Nystatin Vygoris
    • Greece · Nystamysyn
    • Croatia · Pronigyn
    • Hungary · Nystatin Pannonpharma
    • Ireland · Mycostatin (Ready Mixed)
    • Iceland · Nystatin Orifarm, Nystimex
    • Italy · Mycostatin
    • Lithuania · Nystatin Actavis
    • Luxembourg · Biofanal Kombi, Candio-Hermal
    • Netherlands · Nystatine Labaz, Nystatine Rph
    • Norway · Nystatin Orifarm, Nystimex
    • Portugal · Mycostatin
    • Romania · Nistatina Atb, Nistatină Atb
    • Sweden · Nystatin Evolan, Nystatin Orifarm
    • Slovenia · Pronigyn
    • Slovakia · Fungicidin Léčiva, Nystatin Galvex

    Source: European Medicines Agency, Article 57 product data.

    Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

    For developers

    The same record over the API, and the raw payload
    GET /v1/drugs/e0230b1d-c553-4ea4-83e3-7bf1de3c2f99
GET /v1/drugs/e0230b1d-c553-4ea4-83e3-7bf1de3c2f99?format=fhir

    Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

    {
  "form": "Granulat do sporządzania zawiesiny doustnej i stosowania w jamie ustnej",
  "source": "urpl",
  "strength": "2 400 000 j.m./5 g",
  "packaging": "05909990231515 ¦ Rp ¦ Skasowane ¦ 61906\n1 słoik 5 g (24 ml)\n05909991307240 ¦ Rp ¦ 119201\n1 butelka 5,8 g (28 ml)",
  "substance": "Nystatinum 0.552 g",
  "common_name": "Nystatinum",
  "pl_product_id": "100205124",
  "pozwolenie_nr": "02315",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
    API referenceMCP serverPlans

    See everything about nystatin.

    This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

    Try it freeOpen in the console